Generic Drug Tariffs Could Raise US Medicine Costs

Original Article by Amber Tong and Laura Curtis Bloomberg | 22 July 2026

Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.

AI Image | Chat-GPT

Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.

Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.

Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.